摘要
目的探讨坎地沙坦与氟桂利嗪治疗偏头痛的疗效。方法选取100例偏头痛患者,依据盲抽法分为对照组(氟桂利嗪,49例)和观察组(坎地沙坦,51例),两组均同时给予常规治疗,比较两组临床疗效、偏头痛发作情况及不良反应发生情况。结果治疗后,与对照组总有效率81.63%相比,观察组96.08%高,两组VAS评分、头痛发作时间及头痛发作频率均较治疗前低,且观察组较对照组低,有统计学差异(P<0.05);与对照组不良反应发生率16.33%相比,观察组5.88%略低,统计学无差异(P>0.05)。结论偏头痛患者采用坎地沙坦治疗效果更佳,可有效缩短患者头痛发作频率与发作时间,降低疼痛程度,且不良反应发生率较少,安全性高。
Objective To explore the efficacy of candisatan and fluoroquine in the treatment of migraines.Methods The 100 migraine patients treated,according to the blind extraction method,divided into a control group(Fluoroquine,49 cases),observation group(Candisatan,51 cases),both groups were given regular treatment at the same time,comparing the clinical efficacy,migraine attacks and adverse reaction struck in both groups.Results After treatment,compared with the total efficiency of the control group of 81.63%,the observation group was 96.08% higher.the VAS score,the time of headache attack and the frequency of headache attack were lower than before treatment,and the observation group was lower than the control group,and the difference was statistically significant(P<0.05).compared with 16.33% of the adverse reactions in the control group,and the observation group was slightly lower at 5.88%,but the difference was not statistically significant(P>0.05).Conclusion Migraine patients use Candacetan treatment is better,can effectively shorten the frequency and seizure time of headache in patients,reduce the degree of pain,and the incidence of adverse reactions is less,high security.
作者
杨丽娜
Yang Lina(Nanyang Nanshi Hospital Neurology,Nanyang 473000,China)
出处
《哈尔滨医药》
2021年第2期29-30,共2页
Harbin Medical Journal
